Symposium Summary
The Industry/Academia “Next Generation Precision Oncology” Symposium is a unique forum uniting life science innovators from around the world to brainstorm translational oncology research. Presentations and discussions focus on how recent developments in oncology translate into clinical applications and lifesaving therapeutic options for cancer patients.
Symposium Team
Ida Deichaite, PhD
Director, Industry Relations, Moores Cancer Center, Assistant Adjunct Professor, Radiation Medicine and Applied Sciences, UC San Diego
Dr. Ida Deichaite is an Assistant Adjunct Professor in the Department of Radiation Medicine and Applied Sciences. Her research is focused on prostate cancer genomics and head and neck cancer radiogenomics for personalizing radiation therapy to improve outcomes.
In addition, she oversees the translational aspects of oncology at UC San Diego Moores Cancer Center, turning innovation into commercial applications. Her successful partnering with pharma includes overseeing strategy and execution of translational alliances between academia and industry. She is the founder of the Industry/Academia Translational Oncology Symposium, now in its 19th year. This highly visible event was created to support the life sciences ecosystem in San Diego and nationwide.
Dr. Deichaite is widely published in numerous scientific journals. She received her B.A. from Hebrew University, M.Sc. from the Weizmann Institute, Ph.D. from Princeton University, and competed her Research Fellowship at Memorial Sloan Kettering Cancer Center.
Leisa Sutton, MAS
Manager, Translational Programs, Moores Cancer Center, UC San Diego
Leisa Sutton has been with the Industry Relations Office since 2012. In this capacity, she works closely with with Ida Deichaite, PhD, Director of Industry Relations, Assistant Adjunct Professor.
Among her other research and administrative duties, a primary focus of her role is organizing and coordinating the annual Translational Oncology Symposium, Precision Radiation Oncology Symposium, and others.
Her work on collaborative research with UC San Diego investigators and pharma partners has resulted in publications in scientific journals. She received her B.A. from UC San Diego and her M.A.S. from UC San Diego and California Western School of Law.
About the Location
San Diego provides an ideal environment for successful partnerships and collaborations: The intersection of academia, biomedical research, top-notch health care providers, and entrepreneurship allow innovation to abound. San Diego’s position as a global hub for biomedical innovation serves as a role model for translational oncology on a national level.
Please use the following booking links in order to secure the UC San Diego rate at these local hotels: